MCUJF (MCUJF) Stock Price & Analysis
MCUJF (MCUJF) fell 3.57% to USD 0.81 as of July 25, 2026 at 16:31 UTC, according to Nexqual real-time market data.
MCUJF last closed at USD 0.84; the session ranged USD 0.67–0.7 on volume of 2,210 shares. Market capitalization is $9.08M, with a 52-week range of USD 0.67–0.97 (PNK). Source: Nexqual, July 25, 2026 at 16:31 UTC.
Key Statistics (as of July 25, 2026 at 16:31 UTC)
| Price | USD 0.81 |
|---|---|
| Change | ▼ 3.57% (down) |
| Previous Close | USD 0.84 |
| Open | USD 0.7 |
| Day Range | USD 0.67 – 0.7 |
| 52-Week Range | USD 0.67 – 0.97 |
| Volume | 2,210 shares |
| Market Cap | $9.08M |
| Exchange | PNK |
Technical Analysis (MCUJF)
Nexqual's technical model rates MCUJF "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 16:31 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 62.19 (neutral) |
| vs SMA50 | Above (USD 0.76) |
| MACD | 0.03 (positive) |
Analyst Ratings (MCUJF)
Wall Street analysts rate MCUJF "None", per Nexqual as of July 25, 2026 at 16:31 UTC.
| Consensus Rating | None |
|---|
Earnings (MCUJF)
| Next Earnings Date | 2026-08-19 |
|---|
Source: Nexqual, July 25, 2026 at 16:31 UTC.
Financials & Fundamentals (MCUJF)
| Total Revenue | $31.32M |
|---|---|
| Revenue Growth (YoY) | +44.90% |
| Gross Margin | +39.68% |
| Operating Margin | -4.62% |
| Profit Margin | -21.74% |
| ROE | -41.57% |
| Debt / Equity | 6.34 |
| Current Ratio | 1.04 |
| Total Cash | $1.54M |
| Total Debt | $803,000 |
| Free Cash Flow | $-987,750 |
Source: Nexqual, July 25, 2026 at 16:31 UTC.
Financial Health Score (MCUJF)
Nexqual rates MCUJF's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 16:31 UTC.
| Growth | Critical — Revenue -31% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $2M cash, no debt |
| Cash Flow | Weak — FCF negative: -$988K, burning cash |
| Efficiency | Critical — ROE -42%, ROA -15.5% |
Ownership (MCUJF)
| Insider Ownership | +27.30% |
|---|---|
| Institutional Ownership | +23.10% |
| Shares Outstanding | 10.44M |
| Float | 5.27M |
Source: Nexqual, July 25, 2026 at 16:31 UTC.
Leadership (MCUJF)
MCUJF is led by Albert David Friesen (age 78), Founder, CEO, President & Chairman of the Board, per Nexqual as of July 25, 2026 at 16:31 UTC.
| Founder, CEO, President & Chairman of the Board | Albert David Friesen (age 78) |
|---|---|
| Vice President of Scientific & Medical Affairs | Reuben Saba |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CVALF | Covalon Technologies Ltd. | USD 1.54 | ▲ 1.32% |
| PFHO | Pacific Health Care Organizatio | USD 0.83 | ▲ 0% |
| PBSV | Pharma-Bio Serv, Inc. | USD 0.42 | ▼ 27.59% |
| VEXTF | Vext Science Inc. | USD 0.18 | ▲ 2.39% |
| BIOYF | BioSyent Inc. | USD 10.4 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 16:31 UTC. This page is informational and not investment advice.